<span>FilozofADA18.pdf</span>
June 22, 2018

FilozofADA18.pdf

ADA 2018 -- The prevalence of type 2 diabetes (T2DM) and diabetes-associated health burden is increasing world-wide. Diabetic patients are at high risk of developing cirrhosis and liver outcomes, in most cases due to non-alcoholic liver disease (NAFLD). However, liver disease remains a neglected hepatic complication of diabetes.
Read more »
<span>Stackhouse-PetersonPhUSE19s.pdf</span>
February 24, 2019

Stackhouse-PetersonPhUSE19s.pdf

PhUSE US Connect 2019 -- Staying up to date with standards is of the utmost importance, and subtle changes can cause your data to deviate from compliance. With a little bit of SAS, and a little Python, you can easily automate the extraction of CDISC standards metadata using the new SHARE API.
Read more »
<span>Li-3124-SOT19.pdf</span>
March 10, 2019

Li-3124-SOT19.pdf

SOT 2019 - Clonidine is approved for therapy of attention-deficit hyperactivity disorder (ADHD) that is one of the most common neurobehavioral problems mainly afflicting children and youth between 6 and 17 years of age with a high modality from 2% to 18% in USA.
Read more »
<span>Speed Your Neuroscience Trial</span>
March 15, 2019

Speed Your Neuroscience Trial

Developing a drug to treat diseases of Neuroscience is extraordinarily challenging both clinically and operationally. Challenges can include patient heterogeneity, a lack of biomarkers, subjective and insensitive rating scales, enrolling patients at the earliest stage in their disease progression and lengthy trial durations.
Read more »